Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at their meeting held August 12, 2014 recorded approval of Scheme of Arrangement & Reconstruction between Sun Pharmaceutical Industries Ltd., and Sun Pharma Global FZE in the nature of demerger and transfer of the Specified Undertaking of Sun Pharma Global FZE to the Company with effect from the appointed date of May 01, 2013 as per the order of the Honble High Court of Gujarat, at Ahmedabad at its hearing held on July 10, 2014 and accordingly after taking into effect of the above Scheme, approved the revised annual accounts for the year ended March 31, 2014. The Board of Directors of the Company also recommended payment of dividend of Rs. 1.50 (Rupees One and Fifty paise) per equity share of Re.1/- each of the Company for the year ended March 31, 2014, subject to the approval of the members at the ensuing Annual General Meeting of the Company.
Source : BSE - >www.bseindia.com
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.